Ahmed Iqbal 🇬🇧 (@ahmed742iqbal) 's Twitter Profile
Ahmed Iqbal 🇬🇧

@ahmed742iqbal

Senior Clinical Lecturer @sheffielduni & Honorary Consultant in Diabetes & @SheffieldHosp. #T1D #Hypoglycaemia #T2D #DiabTech Representing own views.

ID: 1915340725

linkhttps://www.sheffield.ac.uk/medicine/people/oncology-metabolism/ahmed-iqbal calendar_today28-09-2013 20:56:40

1,1K Tweet

799 Followers

704 Following

Pratik Choudhary (@drpratikc) 's Twitter Profile Photo

Clinical Fellowship in Diabetes Technology ⁦⁦Young Diabetologists and Endocrinologists’ Forum⁩ ⁦Diabetes Technology Network UK DTN-UK⁩ @Leicester Diabetes ⁦🌱Leicester Diabetes⁩ looking for diabetes reg who wants a year with us to gain expertise in diabetes technology - drop me a line if u r interested apps.trac.jobs/job-advert/726…

Irish Endocrine Society (@irishendocrine) 's Twitter Profile Photo

We are delighted to announce that Professor Pratik Choudhary Pratik Choudhary from University of Leicester, will be delivering the Hadden Lecture at 49th IES Annual Meeting 📅 7th & 8th November 2025 📍 Midlands Park Hotel, Portlaoise Abstract submission open irishendocrinesociety.com/login/

We are delighted to announce that Professor Pratik Choudhary <a href="/drpratikc/">Pratik Choudhary</a> from University of Leicester, will be delivering the Hadden Lecture at 49th IES Annual Meeting 
📅 7th &amp; 8th November 2025
📍 Midlands Park Hotel, Portlaoise 

Abstract submission open
irishendocrinesociety.com/login/
The Lancet Diabetes & Endocrinology (@thelancetendo) 's Twitter Profile Photo

New—Non-autoimmune, insulin-deficient #diabetes in children and young adults in #Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study thelancet.com/journals/landi… #T1D #OpenAccess

Diabetes Care, a research journal of the ADA 🌟 (@diabetescareada) 's Twitter Profile Photo

Adults and children progress differently to type 1 diabetes 🎯. Adults show unique antibody patterns 🧬 and risk depending on stage 🚦. Age-specific screening and care are key 🩺. #Type1Diabetes #T1D 💙ADA Professional Publications Read Here➡️ doi.org/10.2337/dc25-0…

Adults and children progress differently to type 1 diabetes 🎯. Adults show unique antibody patterns 🧬 and risk depending on stage 🚦. Age-specific screening and care are key 🩺. #Type1Diabetes #T1D 💙<a href="/ADA_Pubs/">ADA Professional Publications</a> 

Read Here➡️ doi.org/10.2337/dc25-0…
Pratik Choudhary (@drpratikc) 's Twitter Profile Photo

We are looking for a Researcher with a background in stats or data science to join our team. If you have experience in analysing CGM or activity data, or analysing large datasets (eg CPRD), please get in touch 🌱Leicester Diabetes University of Leicester Diabetes Technology Network UK DTN-UK jobs.le.ac.uk/vacancies/1197…

NEJM (@nejm) 's Twitter Profile Photo

CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary:

CONFIDENCE trial: In persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results and Research Summary:
EASD (@easdnews) 's Twitter Profile Photo

🚨#SpeakerHighlight: Everything to know about continuous ketone monitoring! Join Dr. Richard Bergenstal at #EASD2025 in Vienna: 🧬What are the potential challenges of continuous ketone monitoring? 📅Fri, 19 Sept |🕒10:15 - 10:45 CEST |📍Spotlight Stage 👉easd.org/annual-meeting…

🚨#SpeakerHighlight: Everything to know about continuous ketone monitoring!

Join Dr. Richard Bergenstal at #EASD2025 in Vienna:
🧬What are the potential challenges of continuous ketone monitoring?
📅Fri, 19 Sept |🕒10:15 - 10:45 CEST |📍Spotlight Stage

👉easd.org/annual-meeting…
Dr Alo, DO, FACC (@mohammedalo) 's Twitter Profile Photo

CVD Risk Reduction With GLP-1 RAs In T2D 1️⃣ An updated meta-regression was conducted across 10 GLP-1RA CVOTs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony, PIONEER 6, REWIND, AMPLITUDE-O, FLOW, SOUL). 2️⃣ Results showed that each 1% HbA1c reduction → 27% lower HR for MACE. 3️⃣

CVD Risk Reduction With GLP-1 RAs In T2D

1️⃣ An updated meta-regression was conducted across 10 GLP-1RA CVOTs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony, PIONEER 6, REWIND, AMPLITUDE-O, FLOW, SOUL).

2️⃣ Results showed that each 1% HbA1c reduction → 27% lower HR for MACE.

3️⃣
EASD (@easdnews) 's Twitter Profile Photo

⚠️The EU Medicines Agency & Heads of Medicines Agencies warn of a surge in illegal GLP-1 products (e.g. semaglutide, liraglutide, tirzepatide) sold online for weight-loss/ #diabetes. These pose serious health risks. GLP-1s are prescription-only! More 👉 ema.europa.eu/en/news/warnin…

⚠️The EU Medicines Agency &amp; Heads of Medicines Agencies warn of a surge in illegal GLP-1 products (e.g. semaglutide, liraglutide, tirzepatide) sold online for weight-loss/ #diabetes. These pose serious health risks. GLP-1s are prescription-only! 

More 👉 ema.europa.eu/en/news/warnin…
DaVinci (@biancodavinci) 's Twitter Profile Photo

The incredible architecture of Florence Cathedral in Italy. Work on this began in 1296 and the structure was completed in 1436.

Michael Riddell, PhD (@mcriddell1) 's Twitter Profile Photo

Level 3 #hypoglycaemia remains common in #diabetes!. Alexandria Ratzki-LeeWing, PhD and team demonstrate Real‐world incidence and risk factors of level 3 (severe) hypo: dom-pubs.onlinelibrary.wiley.com/doi/10.1111/do…